Sciex
FDA Rule on Laboratory-Developed Tests Could Shake up Clinical Mass Spectrometry Space
The rule could boost Roche's planned launch of an FDA-cleared mass spec system while requiring other vendors to rethink their clinical strategies.
Revvity, Sciex Ink Distribution Deal for Mass Spec Newborn Screening
Under the deal, Revvity's reagent kits for newborn screening from dried blood spots will be used with Sciex's mass spectrometry instruments.
The system, which will launch first in the EU and then the US and China, will be integrated into the company's existing Cobas Pro Integrated Solutions analyzer.
Launched in Europe in 2018 and the US in 2020, the fully automated mass spec-based analyzer failed to gain market traction, in large part due to a limited assay menu.
Danaher Q2 Revenues Spike 19 Percent
For the three months ended July 3, the Washington DC-based conglomerate recorded $5.30 billion in total sales compared to $4.44 billion in the year-ago period.